8999 Nelson Way
Burnaby BC V5A 4B5
Alectos Therapeutics is a privately held pharmaceutical company dedicated to the discovery and development of novel small-molecule therapeutics for the treatment of human disease. The company's focus centers on preclinical CNS drug development, target validation, hit-to-lead optimization, and IND-enabling studies. The Alectos pipeline includes development of novel disease-modifying agents for treatment of Progressive Supranuclear Palsy, Alzheimer’s disease, Parkinson’s disease, and Niemann-Pick type C disease.